The pharma and life sciences industry are set for a game-changing year, with innovation, regulation, and sustainability dominating the agenda. Companies will need to stay ahead to seize opportunities ...

The Economic Crime and Corporate Transparency Act 2023 (ECCTA) will have a significant impact on evolving accountancy practice. John Clarke, Chair of Companies House, outlines how accountants will be ...

AI, sustainability and regulatory push set to tran... The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting ...

As 2025 dawns, accountants find themselves at the heart of an economy still navigating the aftershocks of a global pandemic, seismic political shifts, and eroding institutional trust. From ...

HM Revenue & Customs (HMRC) has launched a voluntary disclosure initiative aimed at companies that have overclaimed research and development (R&D) tax relief, marking a significant step in its ongoing ...